Patents by Inventor Haris Jamil

Haris Jamil has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CELL GROWTH
    Publication number: 20110244571
    Abstract: Methods of preparing pre-engineered surfaces using various nanolithography techniques to generate, isolate, and multiply homogeneous cell populations. Surfaces can be treated by etching before exposure to biological systems like cells. Stem cell applications are described.
    Type: Application
    Filed: October 5, 2009
    Publication date: October 6, 2011
    Inventors: Haris Jamil, James Hussey, Nabil A. Amro
  • Method for treating atherosclerosis employing an aP2 inhibitor and combination
    Publication number: 20090076033
    Abstract: A method is provided for treating atherosclerosis and related diseases, employing an aP2 inhibitor or a combination of an aP2 inhibitor and another antiatheroscletotic agent, for example, an HMG CoA reductase inhibitor such as pravastatin.
    Type: Application
    Filed: April 15, 2008
    Publication date: March 19, 2009
    Inventors: Jeffrey A. Robl, Rex A. Parker, Scott A. Biller, Haris Jamil, Bruce L. Jacobson, Krishna Kodukula, Gokhan Hotamisligil
  • Method for treating diabetes employing an aP2 inhibitor and combination
    Patent number: 7390824
    Abstract: A method is provided for treating diabetes and related diseases, especially Type II diabetes, employing an aP2 inhibitor or a combination of an aP2 inhibitor and another antidiabetic agent such as metformin, glyburide, troglitazone and/or insulin.
    Type: Grant
    Filed: September 7, 1999
    Date of Patent: June 24, 2008
    Assignees: Bristol-Myers Squibb Company, Pesident and Fellows of Harvard College
    Inventors: Jeffrey A. Robl, Rex A. Parker, Scott A. Biller, Haris Jamil, Bruce L. Jacobson, Krishna Kodukula
  • Method for treating atherosclerosis employing an aP2 inhibitor and combination
    Patent number: 7358254
    Abstract: A method is provided for treating atherosclerosis and related diseases, employing an aP2 inhibitor or a combination of an aP2 inhibitor and another antiatherosclerotic agent, for example, an HMG CoA reductase inhibitor such as pravastatin.
    Type: Grant
    Filed: June 21, 2004
    Date of Patent: April 15, 2008
    Assignees: Bristol-Myers Squibb Company, President & Fellows of Harvard College
    Inventors: Jeffrey A. Robl, Rex A. Parker, Scott A. Biller, Haris Jamil, Bruce L. Jacobson, Krishna Kodukula, Gokhan Hotamisligil
  • Combination liposomal formulations
    Publication number: 20060165744
    Abstract: The present invention provides a composition comprising a physiologically acceptable carrier and two or more agents encapsulated in a liposome, wherein the combination of the two or more agents possess the following properties: (1) cytotoxicity to tumor cells, (2) nutritional properties, (3) use in application to nails, hair, skin or lips or (4) activity against parasites and insects. The invention also provides a method of making such a composition. The invention further provides a method of treating cancer when the combination of the two or more agents is cytotoxic to tumor cells.
    Type: Application
    Filed: May 22, 2004
    Publication date: July 27, 2006
    Applicant: NeoPharm, Inc
    Inventors: Haris Jamil, Imran Ahmad, Zafeer Ahmad, Gopal Anyarambhatla
  • Method of inducing apoptosis and inhibiting cardiolipin synthesis
    Publication number: 20060078560
    Abstract: The present invention provides a method for inducing apoptosis within a cell by exposing the cell to an inhibitor of cardiolipin synthesis under conditions sufficient to induce apoptosis within the cell. The method can be used to investigate or treat disorders such as cancer, obesity, and cardiovascular disorders. The invention also provides a pharmaceutical composition including an inhibitor of cardiolipin synthesis and a liposomal carrier.
    Type: Application
    Filed: November 22, 2005
    Publication date: April 13, 2006
    Applicant: NeoPharm, Inc.
    Inventors: Haris Jamil, Moghis Ahmad, Imran Ahmad
  • Method for treating atherosclerosis employing an aP2 inhibitor and combination
    Publication number: 20040229807
    Abstract: A method is provided for treating atherosclerosis and related diseases, employing an aP2 inhibitor or a combination of an aP2 inhibitor and another antiatherosclerotic agent, for example, an HMG CoA reductase inhibitor such as pravastatin.
    Type: Application
    Filed: June 21, 2004
    Publication date: November 18, 2004
    Inventors: Jeffrey A. Robl, Rex A. Parker, Scott A. Biller, Haris Jamil, Bruce L. Jacobson, Krishna Kodukula
  • Method for treating atherosclerosis employing an aP2 inhibitor and combination
    Publication number: 20020035064
    Abstract: A method is provided for treating atherosclerosis and related diseases, employing an aP2 inhibitor or a combination of an aP2 inhibitor and another antiatherosclerotic agent, for example, an HMG CoA reductase inhibitor such as pravastatin.
    Type: Application
    Filed: July 13, 2001
    Publication date: March 21, 2002
    Inventors: Jeffrey A. Robl, Rex A. Parker, Scott A. Biller, Haris Jamil, Bruce L. Jacobson, Krishna Kodukula